[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS4628A - Cell series that produces pain-relieving substances for use in the treatment of pain - Google Patents

Cell series that produces pain-relieving substances for use in the treatment of pain

Info

Publication number
IS4628A
IS4628A IS4628A IS4628A IS4628A IS 4628 A IS4628 A IS 4628A IS 4628 A IS4628 A IS 4628A IS 4628 A IS4628 A IS 4628A IS 4628 A IS4628 A IS 4628A
Authority
IS
Iceland
Prior art keywords
pain
treatment
cell series
produces
relieving substances
Prior art date
Application number
IS4628A
Other languages
Icelandic (is)
Inventor
Saydoff Joel
Original Assignee
Cyto Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyto Therapeutics, Inc. filed Critical Cyto Therapeutics, Inc.
Publication of IS4628A publication Critical patent/IS4628A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS4628A 1995-06-07 1997-12-04 Cell series that produces pain-relieving substances for use in the treatment of pain IS4628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07
PCT/US1996/009629 WO1996040959A1 (en) 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain

Publications (1)

Publication Number Publication Date
IS4628A true IS4628A (en) 1997-12-04

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4628A IS4628A (en) 1995-06-07 1997-12-04 Cell series that produces pain-relieving substances for use in the treatment of pain

Country Status (20)

Country Link
EP (1) EP0833935A1 (en)
JP (1) JPH11507530A (en)
KR (1) KR19990022414A (en)
CN (1) CN1192246A (en)
AR (1) AR004494A1 (en)
AU (1) AU6263696A (en)
BR (1) BR9608746A (en)
CA (1) CA2223246A1 (en)
CZ (1) CZ392497A3 (en)
EE (1) EE9700326A (en)
HU (1) HUP9901191A2 (en)
IL (1) IL122415A0 (en)
IN (1) IN181898B (en)
IS (1) IS4628A (en)
NO (1) NO975545L (en)
PL (1) PL323867A1 (en)
SK (1) SK167997A3 (en)
TR (1) TR199701520T1 (en)
WO (1) WO1996040959A1 (en)
ZA (1) ZA964880B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2331752B (en) * 1997-11-28 2001-01-24 Medical Res Council Vectors
AU6151899A (en) 1998-09-23 2000-04-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of treating chronic pain
AU1324100A (en) * 1998-10-27 2000-05-15 Anticancer, Inc. Method and model for hair pigmentation
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
US20070148129A1 (en) 2003-12-24 2007-06-28 The Walter And Eliza Hall Instiute Of Medical Research Therapeutic agents and uses therefor
CA2566549C (en) 2004-05-12 2014-01-14 The Walter And Eliza Hall Institute Of Medical Research A method for isolating mammary stem cells
DK1910535T3 (en) 2005-06-24 2016-09-26 The Walter And Eliza Hall Inst Of Medical Res Therapeutic pro-apoptotic BH-3-like molecules and method of forming and / or selecting the same
EP2051726B1 (en) 2006-07-18 2018-04-18 University of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
CN105377286B (en) 2013-05-31 2021-07-02 犹他大学研究基金会 CONOTOXIN (CONOTOXIN) peptides, pharmaceutical compositions and uses thereof
CN108884135B (en) 2015-10-27 2024-03-26 昆士兰大学 Therapeutic methods and agents useful therein
CN107964047B (en) * 2017-12-18 2018-11-02 哈尔滨工业大学 Chimeric peptide and its synthetic method based on Tyr-Pro-Trp-Phe-NH2 and neurotensin (8-13) and application
CN112891337A (en) * 2021-03-26 2021-06-04 河北医科大学 Application of galangin and its derivatives in preparing medicine for preventing and treating nervous system diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7568094A (en) * 1993-08-12 1995-03-14 Cytotherapeutics, Inc. Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules

Also Published As

Publication number Publication date
NO975545D0 (en) 1997-12-02
EE9700326A (en) 1998-06-15
JPH11507530A (en) 1999-07-06
AR004494A1 (en) 1998-12-16
WO1996040959A1 (en) 1996-12-19
SK167997A3 (en) 1998-05-06
TR199701520T1 (en) 1998-04-21
NO975545L (en) 1998-02-04
CZ392497A3 (en) 1998-12-16
AU6263696A (en) 1996-12-30
ZA964880B (en) 1997-01-07
IL122415A0 (en) 1998-06-15
KR19990022414A (en) 1999-03-25
IN181898B (en) 1998-10-24
PL323867A1 (en) 1998-04-27
EP0833935A1 (en) 1998-04-08
HUP9901191A2 (en) 1999-08-30
CN1192246A (en) 1998-09-02
BR9608746A (en) 1999-05-11
CA2223246A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
CY2006007I1 (en) USE OF CGMP-PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF IMPOTENCE
ID17156A (en) ANTI-COAGULAN SUBSTANCE USE IN TREATMENT OF TROMBOSIS
EE9800158A (en) Epinastine for use in the treatment of pain
DE69630947D1 (en) PAIN TREATMENT AGENTS
IS4628A (en) Cell series that produces pain-relieving substances for use in the treatment of pain
ATE381353T1 (en) IMPROVEMENTS IN OR TO CONTRAST AGENTS
BR9711663A (en) M-tod and composition for moistened substrate treatment
HUP0103621A2 (en) Fentanyl composition for the treatment of acute pain
FI972205A0 (en) cGmp-PDE inhibitors in the treatment of erectile dysfunction
IL114229A (en) Compositions for applying active substances to or through the skin
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
HK1000781A1 (en) Apparatus and process to ascertain an action, and use of the apparatus and the process
DE69931799D1 (en) ABSORPTION ACCUMULATORS AND PREPARATIONS CONTAINING THEM FOR THE TRANSDERMAL ABSORPTION
IS5504A (en) Composition active in the treatment of impotence
DE69527749D1 (en) Spherical activated carbon for the treatment of abdominal inflammation
DE69506019D1 (en) Pain treatment device
IS4767A (en) PGE-1 containing freeze-dried fat granules for use in the treatment of erectile dysfunction
PT946175E (en) USE OF A COMBINATION OF H +, K + -ATPASE AND GLUCOCORTICIOD INHIBITORS IN THE TREATMENT OF NASA POLLS
DK0898566T3 (en) Substituted benzylamines and their use in the treatment of depression
GB9523335D0 (en) Improvements in or relating to skin treatment materials
GB9816234D0 (en) Compounds for use in the treatment of inflammation
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
DE60003550D1 (en) SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLE AND THE USE THEREOF IN METHODS FOR THERAPEUTIC AND PROPHYLACTIC TREATMENT
IL129460A0 (en) Use of lofexidine in the treatment of behavioral disorders
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia